申请人:The Procter & Gamble Company
公开号:US04847303A1
公开(公告)日:1989-07-11
The present invention involves compounds having the structure: ##STR1## wherein: (a) --A.sup.1 is selected from the group consisting of --OH, --H, and --O.sub.2 CR; (b) --A.sup.2 is selected from the group consisting of unsubstituted or substituted, saturated or unsaturated, straight, branched and cyclic alkyl having from 1 to about 10 carbon atoms; (c)--A.sup.3 is selected from --C(CH.sub.3).sub.3, --Si(CH.sub.3).sub.3, and --CF.sub.3 ; and (d) --Y is selected from certain low molecular weight alkyl chains which terminate in specific unsaturated functional groups: ##STR2## and aldehydes in the form of their acetals; pharmaceutical compositions comprising such compounds; and methods for treating inflammation by administering such compounds.
本发明涉及具有以下结构的化合物:##STR1## 其中:(a) --A.sup.1 选自--OH,--H 和 --O.sub.2 CR 组成的群;(b) --A.sup.2 选自未取代或取代的,饱和或不饱和的,直链、支链和环状的碳原子数为1到约10的烷基;(c)--A.sup.3 选自--C(CH.sub.3).sub.3,--Si(CH.sub.3).sub.3 和 --CF.sub.3 ;以及 (d) --Y 选自以特定不饱和官能团结尾的特定低分子量烷基链:##STR2## 以及以缩醛形式的制剂;包括这类化合物的药物组合物;以及通过给予这类化合物来治疗炎症的方法。